Shashank Bengali was a foreign correspondent for the Los Angeles Times, based in Singapore. He spent five years in Mumbai as South Asia bureau chief and before that covered national security in Washington. He came to The Times from McClatchy Newspapers, where he served as Africa bureau chief, Middle East correspondent and national security editor. He has reported from more than 60 countries — from the wars in Afghanistan and Iraq to the London Olympics — and won or shared in several honors, including The Times’ 2016 Pulitzer Prize for breaking news. A native of the L.A. suburbs, he attended USC and Harvard, where he earned a master’s in public policy, and began his career at the Kansas City Star.
Latest From This Author
Staged car breakdowns, blocked railway tracks and civil servant strikes are putting pressure on the junta and raising fears of a harsh crackdown.
Feb. 17, 2021
Medical personnel and human rights groups say pro-government forces are carrying out sexual abuse in Ethiopia’s Tigray region.
Feb. 11, 2021
Analysts say the military takeover threatens an internationally backed peace process aimed at ending ethnic insurgencies.
Feb. 9, 2021
Myanmar’s civilian leader made a Faustian bargain with the army for political gain, critics say. It ended with her detention in Monday’s coup.
Feb. 1, 2021
The presence of women in India’s biggest mass movement in years reflects profound opposition to a slate of agriculture reforms.
Jan. 27, 2021
Activists see a double standard in social media companies’ response to the Capitol attack and their tolerance for violent rhetoric abroad.
Jan. 15, 2021
Doubts surrounding a homegrown vaccine are among the challenges facing India’s effort to vaccinate 300 million people in six months.
Jan. 14, 2021
In foreign capitals, the violence was seen as an ugly coda to a presidency that bludgeoned democratic norms and embraced autocrats.
Jan. 6, 2021
The family of Wanchalearm Satsaksit, the latest Thai democracy activist to disappear from exile, is waging a lonely search for justice.
Dec. 29, 2020
Poor countries face long waits for injections as the U.S. and others buy up nearly all the global supply of Pfizer and Moderna vaccines.
Dec. 22, 2020